(Q1)Mar 31, 2021 | (FY)Dec 31, 2020 | (Q4)Dec 31, 2020 | (Q3)Sep 30, 2020 | (Q2)Jun 30, 2020 | (Q1)Mar 31, 2020 | (FY)Dec 31, 2019 | (Q3)Feb 28, 2019 | |
---|---|---|---|---|---|---|---|---|
Total revenue | 26.54%756.14K | 26.16%1.51M | 357.37K | 263.01K | 289.73K | 597.58K | 1.2M | 0 |
Operating revenue | 969.02%27.96K | -91.68%2.62K | --0 | --0 | --0 | --2.62K | --31.43K | --0 |
Cost of revenue | -54.68%508 | -63.68%4.41K | 208 | 1.24K | 1.84K | 1.12K | 12.14K | |
Gross profit | 26.69%755.64K | 27.08%1.5M | 357.17K | 261.77K | 287.89K | 596.45K | 1.18M | |
Operating expense | -26.62%4.88M | 49.41%16.32M | 3.88M | 729.88%2.6M | 3.17M | 6.65M | 10.93M | 313.51K |
Selling and administrative expenses | -35.86%3.66M | 84.24%13.15M | --3.31M | 475.08%1.8M | --2.31M | --5.71M | --7.14M | --313.51K |
-General and administrative expense | -35.86%3.66M | 84.24%13.15M | --3.31M | 475.08%1.8M | --2.31M | --5.71M | --7.14M | --313.51K |
Research and development costs | 498.62%709.11K | -34.48%516.58K | --132.31K | --159.14K | --106.67K | --118.46K | --788.48K | ---- |
Depreciation amortization depletion | -5.75%828.36K | -10.63%2.84M | --332K | --786.74K | --843K | --878.9K | --3.18M | ---- |
-Depreciation and amortization | -5.75%828.36K | -10.63%2.84M | --332K | --786.74K | --843K | --878.9K | --3.18M | ---- |
Other operating expenses | -423.15%-323.07K | -2.15%-182.69K | --114.85K | ---147.07K | ---88.71K | ---61.76K | ---178.83K | ---- |
Operating profit | 31.88%-4.12M | -52.12%-14.82M | -3.53M | -646.38%-2.34M | -2.89M | -6.05M | -9.74M | -313.51K |
Net non-operating interest income (expenses) | -155.05%-671.82K | -1,731.94%-2.11M | -895.46K | -7,340.36%-500.45K | -448.51K | -263.41K | -115.06K | 6.91K |
Non-operating interest income | 204.15%806 | -95.83%34.3K | --25.85K | -73.57%1.83K | --6.36K | --265 | --822.38K | --6.91K |
Non-operating interest expense | 155.10%672.63K | 128.51%2.14M | --921.31K | --502.28K | --454.87K | --263.67K | --937.44K | ---- |
Other net income (expenses) | -5,968.04%-50.34M | -132.98%-3.13M | -3.26M | -1.06M | 309.57K | 857.9K | -1.34M | |
Gain on sale of security | -5,123.28%-50M | -86.27%-2.39M | ---3.03M | ---847.62K | --481.62K | --995.43K | ---1.28M | ---- |
Special income (charges) | --0 | 94.01%-5.22K | ---- | ---- | ---- | ---- | ---87.17K | ---- |
-Less:Impairment of capital assets | --0 | -94.01%5.22K | ---- | ---- | ---- | ---- | --87.17K | ---- |
Other non-operating income (expenses) | -146.38%-338.84K | -3,330.97%-742.48K | ---219.07K | ---213.83K | ---172.05K | ---137.53K | --22.98K | ---- |
Income before tax | -910.41%-55.14M | -79.08%-20.06M | -7.68M | -1,172.64%-3.9M | -3.02M | -5.46M | -11.2M | -306.6K |
Income tax | 12.11%-56.62K | -114.25%-255.74K | -107.79K | -44.16K | -39.36K | -64.43K | -119.36K | |
Earnings from equity interest net of tax | ||||||||
Net income | -921.43%-55.08M | -78.71%-19.81M | -7.57M | -1,158.23%-3.86M | -2.99M | -5.39M | -11.08M | -306.6K |
Net income continuous operations | -921.43%-55.08M | -78.71%-19.81M | ---7.57M | -1,158.23%-3.86M | ---2.99M | ---5.39M | ---11.08M | ---306.6K |
Noncontrolling interests | ||||||||
Net income attributable to the company | -921.43%-55.08M | -78.71%-19.81M | -7.57M | -1,158.23%-3.86M | -2.99M | -5.39M | -11.08M | -306.6K |
Preferred stock dividends | ||||||||
Other under preferred stock dividend | ||||||||
Net income attributable to common stockholders | -921.43%-55.08M | -78.71%-19.81M | -7.57M | -1,158.23%-3.86M | -2.99M | -5.39M | -11.08M | -306.6K |
Diluted earnings per share | -400.00%-60 | -103.65%-27 | -12 | -1,263.30%-5 | -4 | -12 | -13.258 | -0.3668 |
Basic earnings per share | -400.00%-60 | -103.65%-27 | -12 | -1,263.30%-5 | -4 | -12 | -13.258 | -0.3668 |
Dividend per share | ||||||||
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | Unqualified Opinion | -- | -- | -- | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data